Ferguson Wellman Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EB
MPWT
CI
MBT
FFBTD
AT
VCM
RT
CT
SVWA
Ferguson Wellman Capital Management's DGX Position: Q3 2026 in Review
Ferguson Wellman Capital Management opened a new position in Quest Diagnostics (DGX) in Q3 2026: 941 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #408 among its holdings. This is a return to the name: Ferguson Wellman Capital Management previously reported a position in DGX as recently as Q4 2021.
Ferguson Wellman Capital Management first reported a position in DGX in Q2 2013 and has held it in 27 quarters since. The position peaked at $562K in Q2 2016. 15 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Ferguson Wellman Capital Management held 941 shares of Quest Diagnostics worth $219K as of Q3 2026.
- Quest Diagnostics was a new Ferguson Wellman Capital Management position in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of Ferguson Wellman Capital Management's portfolio in Q3 2026, its #408 holding.
- Ferguson Wellman Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 27 quarters since.
- Ferguson Wellman Capital Management's Quest Diagnostics position peaked at $562K in Q2 2016.
- 15 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Ferguson Wellman Capital Management's 13F filing for Q3 2026, filed 5 Oct 2026.